Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Contact TAF · Income ≤400% FPL · Covers drug cost only — administration billed separately
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C50.0 C50.1 C50.2 C50.3 C50.4 C50.5 C50.6 C50.8 C50.9 C80.0 C80.1 D05.0 D05.1 D05.9Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J9023
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 855-845-3663, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Tecentriq, Avastin / biosimilars, Imfinzi, Yervoy.
Status shown as of each fund's last verification.
As of June 3, 2026, the The Assistance Fund Breast Cancer Program fund is operating a WAITLIST. Call the foundation to confirm current intake. Verify at time of service: 855-845-3663.
Contact TAF. Covers drug cost only — administration billed separately
Household income must be ≤400% FPL. US resident.
Accepted: commercial, medicare. Not eligible: medicaid.
The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.